November 12, 2025 · Form 4 insider transaction
Reeve Emma sold 7,333 shares of PTC Therapeutics Inc at $74.50 per share, a transaction worth $546.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.